COMMUNIQUÉS West-GlobeNewswire
-
Emblem to supply British Columbia and Saskatchewan markets with high quality cannabis
12/10/2018 - 13:00 -
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
12/10/2018 - 13:00 -
Axsome Therapeutics to Present at Upcoming Investor Conferences
12/10/2018 - 13:00 -
INSYS Therapeutics and UC San Diego’s Center for Medicinal Cannabis Research Add Anxiety in Anorexia Nervosa to Series of Collaborative Cannabidiol (CBD) Studies
12/10/2018 - 12:00 -
BeiGene Announces Updated Results from Phase 1 Clinical Trial of Zanubrutinib in Patients with Waldenström’s Macroglobulinemia
12/10/2018 - 12:00 -
Mesoblast and Tasly Pharmaceutical Group Complete Transaction for Strategic Cardiovascular Partnership in China
12/10/2018 - 12:00 -
Ossur Hf : Q3 2018 Results - Conference call Thursday 25 October at 11:00 CET
12/10/2018 - 11:11 -
Fiasp® is effective at controlling blood sugar levels in children and adolescents living with type 1 diabetes, when compared to conventional insulin aspart
12/10/2018 - 11:01 -
GUERBET : Mise à disposition du Rapport Financier semestriel 2018
12/10/2018 - 10:58 -
Rule 2.9 Announcement
12/10/2018 - 08:00 -
Kiadis Pharma provides regulatory and clinical update on ATIR101
12/10/2018 - 07:01 -
Veritas Pharma Attending CannX International Medical Cannabis Conference in Tel Aviv, Israel
11/10/2018 - 23:55 -
Abattis Bioceuticals Provides Update on Vaporizer Product Line
11/10/2018 - 23:16 -
Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
11/10/2018 - 23:04 -
Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access
11/10/2018 - 22:36 -
Align Technology Expands Invisalign Interactive Brand Experience Pilot Program to Connect More Consumers With Invisalign Doctors
11/10/2018 - 22:21 -
Integra LifeSciences to Host Third Quarter 2018 Earnings Results Conference Call on October 31, 2018
11/10/2018 - 22:05 -
KemPharm Provides Highlights from KOL Investor Event Focused on the ADHD Treatment Landscape
11/10/2018 - 22:05 -
Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock
11/10/2018 - 22:05
Pages